🏥 Tempus is a technology company focused on applying artificial intelligence to healthcare, particularly in oncology diagnostics.
📈 The company has experienced significant growth, with a 65% increase in 2024, and is projected to grow 20-25% in the coming years.
⚠️ Tempus is currently operating at a loss and is not expected to be profitable until late 2026.
🚩 The company’s valuation is considered high, with a projected price-to-earnings ratio of 52 times earnings by 2028.
@InvertirdesdeCero:
“The purchase of Tempus has been what has most caught people’s attention. It is a technology company that was founded in 2015 by Eric Lefkofsky, its current CEO, who has also started other businesses, such as Groupon. This company is interesting, since it is focused on the application of artificial intelligence in the healthcare sector, specifically focusing on oncological diagnoses, but it is also expected that they will be able to take this type of analysis and diagnoses to other branches, such as neurological parts, radiology, and cardiology. It is something that they are trying to evolve. The company affirms that it collects data from 6% of academic medical centers. In addition, they also collect data from 50% of oncologists throughout the United States. This has allowed them to generate an incredible database. They have more than 200 petabytes of data, which is equivalent to about 200,000 terabytes, 200,000 times the storage capacity of what a computer like the one I am using now can have. The technology of Tempus is managing to improve the diagnoses and treatments of oncological patients, thanks to the application of artificial intelligence and that enormous database that they have. This company applies artificial intelligence to the diagnosis, in this case, now of oncological diseases or treatments. The platform analyzes the profiles of patients and chooses the most appropriate treatments for each of them. Resuming, the technological platform of Tempus is already improving the health of some patients, and this is what has generated so much interest to investors and probably to Nancy Pelosi.”
Watch the exact part of the video where @InvertirdesdeCero talks about Tempus here:
View the video on YouTube.
Read more articles by the world’s top 100 analysts on Tempus at the following link. BLOG.
